top of page


Item List
Buesinesswire
COMPaSS™ Personalized Spine Surgery Study Begins Enrollment
Carlsmed® announced today that the first patients have been enrolled in the COMPaSS™ study. COMPaSS, Clinical Outcome Measures in Personalized aprevo® Spine Surgery, is a multi-center post market prospective observational registry. The study will collect data on patients with degenerative spinal conditions and are treated surgically with Carlsmed aprevo devices and will track outcomes for a period of two years.
Recent Posts

Portfolio Company

Where Is Ready, Set, Food! From Shark Tank Today?
Read More: https://www.thedai ...
Daily Meal


bottom of page